9DA5
Crystal structure of human DNPH1 bound to inhibitor 2c
This is a non-PDB format compatible entry.
Experimental procedure
| Experimental method | SINGLE WAVELENGTH |
| Source type | SYNCHROTRON |
| Source details | NSLS-II BEAMLINE 17-ID-1 |
| Synchrotron site | NSLS-II |
| Beamline | 17-ID-1 |
| Temperature [K] | 100 |
| Detector technology | PIXEL |
| Collection date | 2024-01-31 |
| Detector | DECTRIS EIGER X 9M |
| Wavelength(s) | 0.92 |
| Spacegroup name | C 2 2 21 |
| Unit cell lengths | 60.639, 64.999, 128.977 |
| Unit cell angles | 90.00, 90.00, 90.00 |
Refinement procedure
| Resolution | 24.780 - 2.820 |
| R-factor | 0.2002 |
| Rwork | 0.197 |
| R-free | 0.27360 |
| Structure solution method | MOLECULAR REPLACEMENT |
| RMSD bond length | 0.011 |
| RMSD bond angle | 1.226 |
| Data scaling software | Aimless |
| Phasing software | PHASER |
| Refinement software | PHENIX (1.20.1_4487) |
Data quality characteristics
| Overall | Outer shell | |
| Low resolution limit [Å] | 24.780 | 2.970 |
| High resolution limit [Å] | 2.820 | 2.820 |
| Rmerge | 0.150 | 1.019 |
| Rmeas | 0.253 | 1.088 |
| Rpim | 0.085 | 0.376 |
| Total number of observations | 53751 | 7403 |
| Number of reflections | 6432 | 922 |
| <I/σ(I)> | 7.3 | 2.5 |
| Completeness [%] | 99.7 | |
| Redundancy | 8.4 | 8 |
| CC(1/2) | 0.991 | 0.808 |
Crystallization Conditions
| crystal ID | method | pH | temperature | details |
| 1 | VAPOR DIFFUSION, SITTING DROP | 5.5 | 292 | 20% (w/v) PEG 3350 and 8% (v/v) Tacsimate |






